Author

E. J. Kim

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Immunology· 2 Animal Behavior & Cognition· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 4 Research Focus:drug response / drug discovery· 3 Organism:mouse· 3 Organism:rat· 2 Assay:behavioral assay· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1

Frequent Co-Authors

D. B. Lee· 2 shared G. Lee· 2 shared H. Kim· 2 shared H. S. Jun· 2 shared J. H. Jeong· 2 shared J. Y. Maeng· 2 shared J. Y. Mun· 2 shared K. H. Kim· 2 shared

Activity by Year

2021-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. B. Lee

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Mosaic display of stable hemagglutinin monomers induces broad immune responses

H. Kim, S. C. Min, D. B. Lee, J. H. Jeong, E. J. Kim, J. Y. Maeng, J. H. Seok, J.-H. Lee, Y. Jang, U. S. Jang, T. Ysenbaert, J. P. P. Catani, J. Lee, Y. Lee, Y. K. Kim, , K. H. Kim

This study develops a nanoparticle vaccine displaying conserved influenza HA epitopes, inducing broad neutralizing antibodies against multiple viral subtypes.

bioRxiv · Apr 10, 2024 · PreprintBioengineering

T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFa Inflammation.

N. W. Cho, S. M. Guldberg, B. Y. Nabet, J. Z. Yu, E. J. Kim, K. J. Hiam-Galvez, J. L. Yee, R. DeBarge, I. Tenvooren, N. A. Ashitey, F. Lynce, D. A. Dillon, J. M. Rosenbluth, M. H. Spitzer

The paper identifies a novel mechanism of ICI resistance where T cells drive inflammatory resistance via IL-1 and TNF in tumors, with implications for therapy.

bioRxiv · Sep 20, 2022Immunology

Non-catastrophic collapse of VEEV by lethal mutagenesis

B. Alejandro, E. J. Kim, J. Y. Hwang, J. W. Park, M. Smith, D. Chung

This study investigates how Venezuelan Equine Encephalitis Virus (VEEV) responds to RNA mutagen treatment, finding that replication-competent subpopulations persist with lower mutation frequency and increased adaptability.

bioRxiv · Jun 21, 2022 · PreprintMicrobiology

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges

D. B. Lee, H. Kim, J. H. Jeong, E. s. Jang, Y. Y. Chang, S. Roh, H. Jeon, E. J. Kim, S. Y. Han, J. Y. Maeng, S. Magez, M. Radwanska, J. Y. Mun, H. S. Jun, G. Lee, , K. H. Kim

This paper develops a mosaic nanoparticle vaccine, 6RBD-np, that induces full protection against SARS-CoV-2 wild type and Delta variants in mice.

bioRxiv · Feb 18, 2022 · PreprintBioengineering

Pavlovian fear conditioning does not readily occur in rats in naturalistic environments

P. R. Zambetti, B. P. Schuessler, B. Lecamp, A. Shin, E. J. Kim, J. Kim

This study shows that Pavlovian fear conditioning does not occur in rats in naturalistic environments, while nonassociative responses to real threats do.

bioRxiv · Oct 20, 2021Animal Behavior & Cognition

Antigen identification and high-throughput interaction mapping by reprogramming viral entry

C. S. Dobson, A. N. Reich, S. Gaglione, B. E. Smith, E. J. Kim, J. Dong, L. Ronsard, V. Okonkwo, D. Lingwood, M. Dougan, S. K. Dougan, M. E. Birnbaum

This paper introduces RAPTR, a method to identify antigens and map their interactions with immune receptors using viral pseudotyping and single-cell sequencing.

bioRxiv · Sep 18, 2021Immunology